COMP <GO>
PDEX vs PROF // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Pro-Dex Inc. (NASDAQ) VS. Profound Medical Corp. (NASDAQ) • 15-METRIC TALLY: PDEX 6
— PROF 3
■ METRIC PARITY
LAST: $58.16 (-5.58%) • MKT CAP: $199.2M
options-implied-move
—
LAST: $6.57 (+12.12%) • MKT CAP: $214.1M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PDEX VS. PROF)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PDEX | PROF | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 29.30% | 70.80% | -41.50 | PROF | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 23.20% | -35.00% | +58.20 | PDEX | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.5x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -1.47% | -17.93% | +16.46 | PDEX | /fcf-yield <GO> |
| Operating Margin | 16.10% | -60.00% | +76.10 | PDEX | /operating-margins <GO> |
| Net Profit Margin | 13.50% | -60.00% | +73.50 | PDEX | /net-margins <GO> |
| Revenue Growth (YoY) | 23.70% | 65.30% | -41.60 | PROF | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 9.08 | 5.97 | +3.11 | PDEX | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 5/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.7 | 47.0 | +0.70 | PDEX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 18.6x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $199.2M | $214.1M | -$14.9M | PROF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PDEX REV | PROF REV | PDEX GROSS % | PROF GROSS % | PDEX FCF | PROF FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $66.6M | $16.1M | 29.3% | 70.8% | -$2.9M | -$38.4M |
| FY 2024 | $53.8M | $9.7M | 27.0% | 72.2% | $6.2M | -$23.5M |
| FY 2023 | $46.1M | $5.9M | — | — | $5.5M | -$22.6M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PDEX // BETA —
PROF // BETA —